BioSpace News Archive

Cara Therapeutics, Inc., a biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pruritus by selectively targeting peripheral kappa opioid receptors, announced that Derek Chalmers, Ph.D., D.Sc., President and Chief Executive Officer, will participate in a fireside chat at the Jefferies Healthcare Conference on Tuesday, June 1, 2021 at 11:00 a.m. ET.

Increased cultivation capacity will enhance the Company’s ability to produce pharmaceutical grade psilocybin at scale

Progenity, Inc., an innovative biotechnology company, announced the appointment of Sean Lavin, M.D. as Vice President, Business Development, Strategy, and Investor Relations.

Nkarta, Inc., a biopharmaceutical company developing engineered natural killer cell therapies to treat cancer, announced its participation at this upcoming investor conference:

ASLAN Pharmaceuticals (Nasdaq:ASLN), a clinical-stage immunology focused biopharmaceutical company developing innovative treatments to transform the lives of patients, today announced Dr Carl Firth, Chief Executive Officer of the company, will participate in a fireside chat at the Jefferies Virtual Healthcare Conference on Tuesday, 1 June, 2021 at 11:30am ET. The conference will be held from 1-4 June 2021.

United Therapeutics Corporation announced that Mr. James Edgemond, Chief Financial Officer and Treasurer of United Therapeutics, will provide an overview and update on the company’s business during a fireside chat session at the Jefferies Virtual Healthcare Conference.

Newly formed publicly traded company NRx Pharmaceuticals, Inc. (NRx) to be traded under the ticker symbol “NRXP” on the Nasdaq Global Market

Inivata, a leader in liquid biopsy, announced a collaboration with F-star Therapeutics, Inc., a clinical-stage biopharmaceutical company dedicated to developing next generation bispecific immunotherapies to transform the lives of patients with cancer, for the use of Inivata’s RaDaR technology.

Adoption of autotransfusion devices is influenced with largely with increasing occurrences of heart disorders and cardiac surgeries.

Medivir AB announces that the company will present at the virtual meeting ABGSC Life Science Summit, , May 25.